drugset / Trial / NCT01971645

Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy

NCT01971645

Phase 3 Completed 77 enrolled Nationwide Children's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

If preservative-free dexamethasone 0.1 mg/kg (max dose 4 mg) is added to ropivacaine 0.5% 2 mg/kg (max dose 100 mg), then post-PACU opioid consumption will be reduced by 33%.

Timeline

Start
2014-07
Primary completion
2016-07
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.1 mg/kg Other
Background Ropivacaine Other / unclassified 2 mg/kg Other

Indications